Report Overview

The UK Rheumatology therapeutics market size stood at around USD 1.109 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The market in the United Kingdom is projected to show a nominal growth over the next five years on account of the high prevalence of rheumatic diseases in the country coupled with the presence of a world-class healthcare sector of the country. According to the United Kingdom National Health Service, more than 10 million people in the country suffer from arthritis and numerous conditions. This, in turn, is anticipated to significantly drive the demand for various types of anti-rheumatic drugs and thus positively impact the market growth in the country in the coming years. Furthermore, the growing healthcare expenditure further enables the citizens to avail costly treatments and medicines which is also projected to positively impact the market growth in the United Kingdom throughout the forecast period.



Market Drivers

The major factors that are driving the market growth throughout the region include the moderate incidence of numerous rheumatic diseases in various countries of the region. Furthermore, the presence of the state-of-art pharmaceutical industry in major countries of the UK region is also anticipated to be one of the key factors driving market growth throughout the forecast period. The booming investments in the pharmaceutical R&D in the region is further widening up the opportunities for the market to grow in the coming years.

With the growing number of geriatric people, aged 65 years and above in the United Kingdom, the number of age-associated diseases such as joint pains, back pain, and rheumatoid arthritis among others, hence the market for various types of antirheumatic drugs will also continue to soar due to their requirement for disease treatment. According to the World Bank estimates, the geriatric population (65 years of age or older) in the United Kingdom has grown from a population size of 11.706 million in 2015 to a population size of 12.231 million in 2018.